HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pablo Matar Selected Research

2-amino-3-chlorobutyric acid

8/2012Modulation of IL-10/IL-10R expression by mafosfamide, a derivative of 4-hydroxycyclophosphamide, in a rat B-cell lymphoma.
1/2010The immune response and the therapeutic effect of metronomic chemotherapy with cyclophosphamide.
1/2002The antimetastatic effect of a single low dose of cyclophosphamide involves modulation of galectin-1 and Bcl-2 expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pablo Matar Research Topics

Disease

18Neoplasms (Cancer)
12/2012 - 01/2002
6Lymphoma (Lymphomas)
08/2012 - 01/2002
5Colorectal Neoplasms (Colorectal Cancer)
09/2015 - 06/2009
3Carcinoma (Carcinomatosis)
12/2012 - 06/2011
3B-Cell Lymphoma (Lymphoma, B Cell)
08/2012 - 01/2005
3Neoplasm Metastasis (Metastasis)
08/2012 - 10/2004
3Breast Neoplasms (Breast Cancer)
01/2012 - 01/2003
2Sarcoma (Soft Tissue Sarcoma)
01/2010 - 01/2003
1Body Weight (Weight, Body)
01/2010
1Cardiotoxicity
05/2008

Drug/Important Bio-Agent (IBA)

10Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2015 - 01/2002
5Interleukin-12 (IL 12)IBA
09/2015 - 12/2009
3Interleukin-10 (Interleukin 10)IBA
08/2012 - 01/2002
32-amino-3-chlorobutyric acidIBA
08/2012 - 01/2002
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2012 - 01/2005
2Interleukin-10 ReceptorsIBA
08/2012 - 01/2005
2Doxorubicin (Adriamycin)FDA LinkGeneric
05/2008 - 01/2003
2Lovastatin (Mevacor)FDA LinkGeneric
05/2008 - 01/2003
2Proteins (Proteins, Gene)FDA Link
01/2005 - 01/2003
2Gefitinib (Iressa)FDA Link
10/2004 - 04/2003
2Tyrosine Kinase InhibitorsIBA
10/2004 - 04/2003
2ErbB Receptors (EGF Receptor)IBA
10/2004 - 04/2003
1HymecromoneIBA
09/2015
14-hydroxycyclophosphamideIBA
08/2012
1mafosfamideIBA
08/2012
1Therapeutic UsesIBA
01/2010
1Hyaluronic Acid (Hyaluronan)IBA
06/2009
1Antineoplastic Agents (Antineoplastics)IBA
05/2008
1Neoplasm Antigens (Tumor Antigens)IBA
11/2007
1Messenger RNA (mRNA)IBA
01/2005
1DNA (Deoxyribonucleic Acid)IBA
10/2004
1Monoclonal AntibodiesIBA
10/2004
1Cetuximab (Erbitux)FDA Link
10/2004
1Complementary DNA (cDNA)IBA
10/2004
1Mitogen-Activated Protein KinasesIBA
10/2004
1LigandsIBA
04/2003
1Epidermal Growth Factor (EGF)IBA
04/2003
1Neuregulin-1 (Neuregulin 1)IBA
04/2003
1HSP27 Heat-Shock ProteinsIBA
01/2003
1Pharmaceutical PreparationsIBA
01/2003
1PlasminogenIBA
07/2002
1Conditioned Culture MediaIBA
07/2002
1AngiostatinsIBA
07/2002
1Carrier Proteins (Binding Protein)IBA
01/2002
1Galectin 1 (LGALS1)IBA
01/2002
1Alkylating AgentsIBA
01/2002
1CytokinesIBA
01/2002
1beta-galactosideIBA
01/2002

Therapy/Procedure

6Immunotherapy
09/2015 - 11/2007
4Therapeutics
08/2012 - 05/2008
4Drug Therapy (Chemotherapy)
01/2012 - 01/2002
3Immunomodulation
01/2012 - 01/2002
1Injections
01/2010